Skin Cancer patient, BIO105 Introductory Biology, David Champlin, USM

Overview

David Champlin explains how a chromosome 17-to-22 translocation associated with dermatofibrosarcoma protuberans (DFSP) joins COL1A1 and PDGFB. The fusion places PDGFB under skin-active COL1A1 regulatory control, causing skin cells to release a growth signal that activates their own PDGF receptors and drives cell-cycle progression.

Key takeaways

The characteristic chromosome 17;22 translocation joins COL1A1 and PDGFB, a rearrangement that can be identified in biopsy material.
A gene fusion can alter more than a protein’s coding sequence: the COL1A1 promoter redirects PDGFB expression into skin cells.
In the cancer mechanism described, skin cells release PDGF and stimulate their own PDGF receptors, forming an autocrine positive-feedback loop.
PDGF receptor signaling activates phosphorylation pathways that encourage progression through the G1-to-S transition of the cell cycle.
The example illustrates how cells with the same DNA can produce different proteins because promoters and other regulatory sequences control gene expression.

Chapters

0:00 Microscopically Visible t(17;22) Chromosome Translocation

Many DNA mutations change a single A, G, C, or T letter and cannot be seen with a microscope; this cancer-associated mutation is a larger chromosome rearrangement.
Chromosomes 17 and 22 break at specific sites and rejoin, creating a translocation that clinicians can recognize in biopsy cells.
Humans have 23 chromosome pairs, numbered 1 through 22 plus the sex chromosomes; the characteristic rearrangement involves chromosomes 17 and 22.

2:30 How COL1A1 and PDGFB Form a Cancer-Associated Gene Fusion

Biochemical analysis identifies breakpoints in PDGFB and COL1A1, a gene that encodes collagen found in connective tissue.
The rearrangement creates fused genetic material from both genes; Champlin connects this to gene expression and protein production.
PDGF signaling normally binds a PDGF receptor and can stimulate the cell cycle, while collagen is ordinarily produced by cells such as those in the skin.

5:30 Skin-Specific PDGFB Expression Creates an Autocrine Growth Loop

Although cells generally share the same DNA, regulatory regions such as promoters control where a gene is expressed; insulin, for example, is produced in the pancreas.
The COL1A1 promoter normally directs expression in skin; when joined to PDGFB, it drives PDGFB production in skin cells.
The resulting growth factor is released by exocytosis and binds PDGF receptors on the same cell, creating an autocrine, positive-feedback signal.
PDGF receptor signaling activates kinase phosphorylation and pushes cells through the G1-to-S cell-cycle checkpoint, promoting growth even without a wound.

Summary, takeaways, and chapters were generated by AI from the video's transcript and may contain errors. The video belongs to its creator, The New Evolution for Everyone.